CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope - PubMed (original) (raw)
Comparative Study
CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope
Junbao Yang et al. J Autoimmun. 2008 Aug.
Abstract
Recent studies suggest that insulin is a primary autoantigen for type 1 diabetes. Several studies have identified preproinsulin (PPI) 76-90 as an immunodominant CD4+ T cell epitope. We developed a class II tetramer reagent using a modified PPI peptide with a lysine to serine substitution at position 88 (PPI 78-90(88S)) that has high binding affinity to DRA1*0101/DRB1*0401 (DR0401). Using this tetramer, positive responses were observed from both DR0401 healthy and type 1 diabetic subjects when T cells were stimulated with the PPI 78-90(88S) peptide. Seventy percent of these T cells proliferated in response to both the wild type PPI 76-90 and PPI 78-90(88S) peptides. However, when T cells were stimulated with wild type peptide and assayed with DR0401/PPI 78-90(88S), positive responses were only detected in the diabetic group but not in healthy subjects. When highly purified CD4+CD25-CD45RA+ T cells were stimulated with PPI 78-90(88S) peptide in the absence of antigen-presenting cells, T cells from the diabetic group were able to respond to peptide stimulation, while T cells from healthy subjects were not. These data suggest that T cells from type 1 diabetic subjects have a lower threshold of activation in response to PPI peptide stimulation as compared to healthy subjects.
Similar articles
- Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
Danke NA, Yang J, Greenbaum C, Kwok WW. Danke NA, et al. J Autoimmun. 2005 Dec;25(4):303-11. doi: 10.1016/j.jaut.2005.08.007. Epub 2005 Oct 24. J Autoimmun. 2005. PMID: 16249070 - Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.
Durinovic-Belló I, Schlosser M, Riedl M, Maisel N, Rosinger S, Kalbacher H, Deeg M, Ziegler M, Elliott J, Roep BO, Karges W, Boehm BO. Durinovic-Belló I, et al. Diabetologia. 2004 Mar;47(3):439-450. doi: 10.1007/s00125-003-1315-1. Epub 2004 Jan 24. Diabetologia. 2004. PMID: 14745491 - GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
Oling V, Marttila J, Ilonen J, Kwok WW, Nepom G, Knip M, Simell O, Reijonen H. Oling V, et al. J Autoimmun. 2005 Nov;25(3):235-43. doi: 10.1016/j.jaut.2005.09.018. Epub 2005 Nov 2. J Autoimmun. 2005. PMID: 16263242 - Tetramer analysis of human autoreactive CD4-positive T cells.
Nepom GT. Nepom GT. Adv Immunol. 2005;88:51-71. doi: 10.1016/S0065-2776(05)88002-2. Adv Immunol. 2005. PMID: 16227087 Review. - Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetes.
Baker RL, Jamison BL, Haskins K. Baker RL, et al. Curr Opin Endocrinol Diabetes Obes. 2019 Aug;26(4):195-200. doi: 10.1097/MED.0000000000000490. Curr Opin Endocrinol Diabetes Obes. 2019. PMID: 31166225 Free PMC article. Review.
Cited by
- First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers.
Van Rampelbergh J, Achenbach P, Leslie RD, Kindermans M, Parmentier F, Carlier V, Bovy N, Vanderelst L, Van Mechelen M, Vandepapelière P, Boitard C. Van Rampelbergh J, et al. BMC Med. 2024 Jun 21;22(1):259. doi: 10.1186/s12916-024-03476-y. BMC Med. 2024. PMID: 38902652 Free PMC article. Clinical Trial. - Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes.
Wenzlau JM, DiLisio JE, Barbour G, Dang M, Hohenstein AC, Nakayama M, Delong T, Baker RL, Haskins K. Wenzlau JM, et al. Front Immunol. 2022 Aug 10;13:926650. doi: 10.3389/fimmu.2022.926650. eCollection 2022. Front Immunol. 2022. PMID: 36032090 Free PMC article. - Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes.
Linsley PS, Barahmand-Pour-Whitman F, Balmas E, DeBerg HA, Flynn KJ, Hu AK, Rosasco MG, Chen J, O'Rourke C, Serti E, Gersuk VH, Motwani K, Seay HR, Brusko TM, Kwok WW, Speake C, Greenbaum CJ, Nepom GT, Cerosaletti K. Linsley PS, et al. JCI Insight. 2021 Nov 22;6(22):e151349. doi: 10.1172/jci.insight.151349. JCI Insight. 2021. PMID: 34806648 Free PMC article. - Proinsulin-specific T-cell responses correlate with estimated c-peptide and predict partial remission duration in type 1 diabetes.
Musthaffa Y, Hamilton-Williams EE, Nel HJ, Bergot AS, Mehdi AM, Harris M, Thomas R. Musthaffa Y, et al. Clin Transl Immunology. 2021 Jul 26;10(7):e1315. doi: 10.1002/cti2.1315. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34336205 Free PMC article. - Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes-Associated HLA Class II Molecules.
Ihantola EL, Ilmonen H, Kailaanmäki A, Rytkönen-Nissinen M, Azam A, Maillère B, Lindestam Arlehamn CS, Sette A, Motwani K, Seay HR, Brusko TM, Knip M, Veijola R, Toppari J, Ilonen J, Kinnunen T. Ihantola EL, et al. J Immunol. 2020 May 1;204(9):2349-2359. doi: 10.4049/jimmunol.1901079. Epub 2020 Mar 30. J Immunol. 2020. PMID: 32229538 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials